FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $423,000 | -11.9% | 26,714 | -4.3% | 0.01% | -12.5% |
| Q1 2018 | $480,000 | -21.3% | 27,923 | +0.4% | 0.01% | -20.0% |
| Q4 2017 | $610,000 | -49.8% | 27,823 | -6.3% | 0.01% | -64.3% |
| Q3 2017 | $1,215,000 | +35.9% | 29,678 | 0.0% | 0.03% | +27.3% |
| Q2 2017 | $894,000 | -16.8% | 29,678 | -0.1% | 0.02% | -18.5% |
| Q1 2017 | $1,074,000 | -27.8% | 29,698 | 0.0% | 0.03% | -32.5% |
| Q4 2016 | $1,488,000 | -31.9% | 29,698 | -28.7% | 0.04% | -36.5% |
| Q3 2016 | $2,184,000 | +27.5% | 41,628 | +0.5% | 0.06% | +23.5% |
| Q2 2016 | $1,713,000 | +276.5% | 41,428 | +269.9% | 0.05% | +264.3% |
| Q1 2016 | $455,000 | -1.3% | 11,200 | +0.9% | 0.01% | +7.7% |
| Q4 2015 | $461,000 | +99.6% | 11,100 | -26.0% | 0.01% | +85.7% |
| Q3 2015 | $231,000 | -37.6% | 15,000 | +0.7% | 0.01% | -36.4% |
| Q2 2015 | $370,000 | – | 14,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|